Date: September 30, 2024
Attention: Providers
Effective date: September 25, 2024
Call to action: Effective September 25, 2024, the Texas Health and Human Services (HHS) removed non-preferred status from generic sildenafil oral suspension This is in response to the discontinuation of brand Revatio suspension by the manufacturer.
The preferred status of the brand name Revatio oral suspension will not change to allow any current stock to be used.
Next step for Providers: Prescribers are encouraged to proactively obtain a prescription for the preferred alternatives to avoid disruption in patient’s therapy. Prescribers should share this communication with their staff.
Please see below for the list of impacted drugs (of note, the approval is NDC-specific):
| Preferred Medication NDC | Preferred Medication | Type of Change | Effective Date |
| 00591405094 | SILDENAFIL 10 MG/ML ORAL SUSP | Generic now preferred | September 25, 2024 |
| 27241017529 | SILDENAFIL 10 MG/ML ORAL SUSP | Generic now preferred | September 25, 2024 |
| 31722013631 | SILDENAFIL 10 MG/ML ORAL SUSP | Generic now preferred | September 25, 2024 |
| 59762205801 | SILDENAFIL 10 MG/ML ORAL SUSP | Generic now preferred | September 25, 2024 |
| 68180028301 | SILDENAFIL 10 MG/ML ORAL SUSP | Generic now preferred | September 25, 2024 |
| 69238157401 | SILDENAFIL 10 MG/ML ORAL SUSP | Generic now preferred | September 25, 2024 |
| 70710171604 | SILDENAFIL 10 MG/ML ORAL SUSP | Generic now preferred | September 25, 2024 |
| 70954016810 | SILDENAFIL 10 MG/ML ORAL SUSP | Generic now preferred | September 25, 2024 |
| 72205005976 | SILDENAFIL 10 MG/ML ORAL SUSP | Generic now preferred | September 25, 2024 |
If you have any questions, please email TCHP Pharmacy at: tchppharmacy@texaschildrens.org.
For access to all provider alerts,log into:
www.thecheckup.org or www.texaschildrenshealthplan.org/for-providers.